Member Info for avctIPmatters

Note : https://www.medica-tradefair.com/vis/v1/en/search?oid=80396&lang=2&_query=CORIS+BIOCONCEPT

https://www.medica-tradefair.com/en/Exhibit

--------------

Coris team building - first prize get to go to the medica-tradefair in November .

https://fr.linkedin.com/posts/coris-bioconcept_teamcoris-teambuilding-espritd%C3%A9quipe-activity-7251574621030821889-kS-9

-----------------------------

CORIS BIOCONCEPTCORIS BIOCONCEPT

2,732 followers2,732 followers

3h • 3 hours ago

Follow

✨ Flashback Monday! ✨

Today, we wanted to share with our network a special moment captured during our very last Team Building. This is the perfect opportunity to introduce you to the entire Coris team!

This Team Building was an opportunity to strengthen our bonds, to share our ideas, to discover each other with colleagues, but above all to have a lot of fun 🎉

Rest assured, behind every test, every innovation, there is a human team, united by a common vision: the health and safety of all. 🌍❤️

hashtag#TeamCoris hashtag#TeamBuilding hashtag#EspritdÉquipe hashtag#OneTeam hashtag#WorkHardPlayHard "

Wetherby location removed

Not sure what has changed but website changed today

https://avacta.com/

https://avacta.com/ 0 2024-10-14 10:00 +00:00

Hopefully Avacta done all the hard work already at this stage with" pre|CISIONTM platform is a proprietary warhead delivery system"

Might be a better link below - Just need partners to licence the technology ,the more the better - concurrent royalties/sales /upfront payments roll in & partners take own drugs through to approval - Avacta keep the IP and support the drug chemistry required to fit /use the technology

https://tinyurl.com/3wcpc4fb

"I agree with your '10 separate pre clinical studies - 10 seperate entries in the pipeline"

POC : Delivery system has been proven - below profound words courtesy of Twitter

"the cost of subsequent programs is relatively small "

https://x.com/Blueberrymgmnt

Https://www.launchdiagnostics.com/product/clonit-cardiovascular-disease-real-time-pcr-kits/

---------------

Launch Diagnostics LimitedLaunch Diagnostics Limited

1,931 followers1,931 followers

1d • 1 day ago

World Thrombosis Day, observed on October 13, raises awareness about the risks of blood clots (thrombosis) and their severe implications, such as stroke, heart attack, and deep vein thrombosis. It highlights the importance of early detection and prevention to reduce complications.

Clonit’s PCR kits provide a complete coverage of frequent as well as rare mutations in genes related to the coagulation pathway reported to constitute risk factors for thrombophilia.

For further information, please visit https://lnkd.in/eiD3SiC9

or contact your local Territory Manager.

hashtag#worldthrombosisday hashtag#launchdiagnostics hashtag#clonit hashtag#cardiovasculardisease hashtag#thrombophilia

--------------

Thrombosis And Hemostasis Biomarkers Market To Reach $7.92 Billion By 2030

June 2023 | Report Format: Electronic (PDF)

Thrombosis And Hemostasis Biomarkers Market Growth & Trends

The global thrombosis and hemostasis biomarkers market size is expected to reach USD 7.92 billion by 2030, expanding at a CAGR of 5.90% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rapid growth of the market is attributable to factors such as the increasing prevalence of chronic diseases such as pancreatic cancer, the rise in the geriatric population, the growing demand for personalized medicines, and advancements in technology."

https://www.grandviewresearch.com/press-release/global-thrombosis-hemostasis-biomarkers-market

Good Morning Bella6532

This report backs you up : Maybe future Next Gen Vaccine work for Avacta /TomlinsonlLeeds Scietntists to look at in the lab .

https://www.bmj.com/content/387/bmj.q2248

"AMR: Increased vaccine use could cut global antibiotic use by 22%, WHO estimates

Increasing the use of vaccines could help tackle the growing threat of antimicrobial resistance (AMR) by reducing the need for antibiotics by 22% globally—or 2.5 billion defined daily doses—every year, a report by the World Health Organization has said.1

The report, published on 10 October, evaluated the impact of 44 vaccines targeting 24 pathogens. It estimated that increasing the use of vaccines that are already available, as well as developing new vaccines, could prevent 515 000 deaths every year by reducing infections, transmission of pathogens, antibiotic use, and the evolution of resistant genes.

In 2019 around five million people died …"

Find it difficult to spell some of these scientific words let alone understand what they mean : Glossary helps

https://avacta.com/wp-content/uploads/2024/04/Glossary.pdf

Seem to like ADC's --- maybe have a peep at what Avacta are doing .

"Meanwhile, the race to develop ADC into the industry’s next blockbuster medicine has heated up, with pharma juggernauts from Pfizer and AbbVie wading into the space and spawning some of the industry’s biggest acquisitions in recent years. A growing legion of Chinese biotechs have also come up with promising ADC candidates, earning them partnerships with leading global drugmakers."

https://www.japantimes.co.jp/business/2024/10/11/companies/daiichi-sankyo-cancer-drug/

Note a few the inventors listed on LG patent

https://patents.justia.com/inventor/adam-estelle

Thanks for sharing

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024200988&_gid=202440

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024200987&_gid=202440

Hopefully this old ghoul still be around to enjoy the spoils -the value is owning the IP assets .Hopefully Avacta in the driving seat with regard to future partner involvement . . Important to get this new technology treament into cancer patients ASAP . Be intersting to see how it all pans out .

Ultimately shoulld be a win /win for everyone involved & certainly well worth the wait .

Nasdaq sorry finger trouble more haste less speed .

NASADAQ not Nasaqno

You can raise money like this if on Nasaqno no need for IPO.

https://elicio.com/press_releases/elicio-therapeutics-announces-proposed-public-offering/

Nothing on sec filings or website , ?

https://elicio.com/investors/sec-filings/

https://elicio.com/contact/

Intersting they did a reverse takeover to get on Nasdaq avoided doing IPO - Might be an idea for Avacta to consider

Guess we will get to see the Avacta posters officially soon

Not sure why twitter accont deleted the abstract anyway try this one ---picture not pefect but exciting read.

https://x.com/Smiffy_O/status/1843960537165742164

Dr. Gëzim Lahu Also works for Takeda.

Thanks for sharing : Info on Dr. Gëzim Lahu

Gëzim is a quantitative clinical pharmacologist, toxicologist

https://www.thinkq2.com/index.html#content5-m

AVA6103 early data looks impressive .